Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0278488 (
metastatic breast cancer
)
7,812
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In photoelectrochemical (PEC) detection, enhancing the PEC signal and depressing the blank signal are conducive to improve the sensitivity. Because the carbon nanotube (CNT) effectively transfers photogenerated electrons from SnSe to the electrode, the composite nanomaterial CNTs/SnSe generates a strong PEC signal.
Methionine
(
Met
), AuNPs, and probe DNA are woven together forming a nanoprobe which is used as a quencher to quench the PEC signal of CNTs/SnSe. When the nanoprobe and CNTs/SnSe are modified onto the electrode, there is a low blank signal. In the presence of
metastatic breast cancer
cells, the cells interact with the aptamer of dsDNA; concomitantly, cDNA is released to trigger catalytic hairpin assembly (CHA). As a result, a new dsDNA which has an overhang is formed. The nanoprobe on the surface of the electrode hybridizes with the newly formed dsDNA. Subsequently, the nanoprobe is released from the surface of the electrode and the quenching effect between the nanoprobe and the CNTs/SnSe disappears. The PEC aptasensor is linear in the concentration range of 300-5,000 cells/mL, and the detection limit is 180 cells/mL under optimized conditions. The relative standard deviation (RSD) is 3.6% at 10,000 cells/mL. This work demonstrates a promising strategy using CNTs/SnSe as the photoactive material and
Met
-AuNPs as the quencher to establish a PEC aptasensor with a high PEC response and low blank signal. It can be used to detect bioactive substances at ultralow levels prospectively. Graphical abstract.
...
PMID:Photoelectrochemical aptasensor with low background noise. 3308 57
<< Previous
1
2
3